Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.
Description
CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.
API Access
Has API
No
API Access
Has API
No
Integrations
Ambra Health
No
Charles River IMS
Yes
Microsoft 365
Yes
NVIDIA DRIVE
Yes
Integrations
Ambra Health
Yes
Charles River IMS
No
Microsoft 365
No
NVIDIA DRIVE
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Aiforia
Country
United States
Website
www.aiforia.com
Vendor Details
Company Name
CureMetrix
Founded
2014
Country
United States
Website
curemetrix.com
Product Features
Product Features
Radiology
Audit Trail
No
Billing & Invoicing
No
Claims Management
No
EDI
No
EMR HL7 Bridge
No
Image Fusion
No
PACS Integration
No
Patient Scheduling
No
Scanning Input
No
Teleradiology
No
Wait List Management
No